GEN Exclusives

More »

GEN News Highlights

More »
Nov 20, 2007

Scientists Uncover Mechanism for Retinoic Acid Regulation

  • University of California Irvine (UCI) researchers discovered how embryonic cells may regulate levels of retinoic acid, a derivative of vitamin A that is used to treat certain types of leukemia and acne.

    The investigators used zebrafish embryos genetically engineered to be unable to make enough retinoic acid and become fluorescent in response to retinoic acid when illuminated with an ultraviolet light. The UCI scientists implanted tiny retinoic acid-soaked beads, which gradually released retinoic acid into the embryos, and then tracked how the retinoic acid moved within the embryos.

    The scientists found that if the level becomes too high, an enzyme called Cyp26a1 degrades the excess, bringing the concentration back to normal. When levels drop too low, proteins called fibroblast growth factors (Fgfs) stop the retinoic acid from degrading as rapidly.

    “Those two things work together to keep the whole system adjusted to the right level,” says Thomas Schilling, Ph.D., associate professor of developmental and cell biology. “Retinoic acid induces its own degradation, and Fgfs, also present in the embryo, have the opposite effect by inhibiting retinoic acid degradation.”

    The study is published this week in PLoS Biology


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »